{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:56:14Z","timestamp":1790470574868,"version":"4.1.0"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Achromobacteria are ubiquitous environmental organisms that may also become opportunistic pathogens in certain conditions, such as cystic fibrosis, hematologic and solid organ malignancies, renal failure, and certain immune deficiencies. Some members of this genus, such as xylosoxidans, cause primarily nosocomially acquired infections affecting multiple organ systems, including the respiratory tract, urinary tract, and, less commonly, the cardiovascular and central nervous systems. Despite an increasing number of published case reports and literature reviews suggesting a global increase in achromobacterial disease, most clinicians remain uncertain of the organism\u2019s significance when clinically isolated. Moreover, effective treatment can be challenging due to the organism\u2019s inherent and acquired multidrug resistance patterns. We reviewed all published cases to date of non\u2013cystic fibrosis achromobacterial lung infections to better understand the organism\u2019s pathogenic potential and drug susceptibilities. We found that the majority of these cases were community acquired, typically presenting as pneumonias (88%), and were most frequent in individuals with hematologic and solid organ malignancies. Our findings also suggest that achromobacterial lung infections are difficult to treat, but respond well to extended-spectrum penicillins and cephalosporins, such as ticarcillin, piperacillin, and cefoperazone.<\/jats:p>","DOI":"10.1513\/annalsats.201406-288fr","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T19:10:34Z","timestamp":1424718634000},"page":"252-258","source":"Crossref","is-referenced-by-count":129,"title":["<i>Achromobacter<\/i>\n                    Respiratory Infections"],"prefix":"10.1093","volume":"12","author":[{"given":"Colin E.","family":"Swenson","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, College of Medicine, University of Florida, Gainesville, Florida; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxana T.","family":"Sadikot","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, College of Medicine, University of Florida, Gainesville, Florida; and"},{"name":"Department of Veterans Affairs, Atlanta Veterans Affairs Medical Center and Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,1]]},"reference":[{"key":"2026012303405554600_bib1","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1128\/AEM.02293-13","article-title":"Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates","volume":"79","author":"Amoureux","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"2026012303405554600_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/clinids\/23.3.569","article-title":"Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature","volume":"23","author":"Duggan","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2026012303405554600_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/jcm.19.2.140-143.1984","article-title":"Nosocomial colonization and infection by Achromobacter xylosoxidans","volume":"19","author":"Reverdy","year":"1984","journal-title":"J Clin Microbiol"},{"key":"2026012303405554600_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1348-0421.1971.tb00607.x","article-title":"Achromobacter xylosoxidans n. sp. from human ear discharge","volume":"15","author":"Yabuuchi","year":"1971","journal-title":"Jpn J Microbiol"},{"key":"2026012303405554600_bib5","first-page":"1","article-title":"Twenty-seven years with the nomenclature of Achromobacter xylosoxidans [in Japanese]","volume":"10","author":"Yabuuchi","year":"1999","journal-title":"Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi"},{"key":"2026012303405554600_bib6","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1007\/s00253-013-5018-3","article-title":"Comparative genome characterization of Achromobacter members reveals potential genetic determinants facilitating the adaptation to a pathogenic lifestyle","volume":"97","author":"Li","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"key":"2026012303405554600_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.syapm.2013.06.005","article-title":"Classification of Achromobacter genogroups 2, 5, 7 and 14 as Achromobacter insuavis sp. nov., Achromobacter aegrifaciens sp. nov., Achromobacter anxifer sp. nov. and Achromobacter dolens sp. nov., respectively","volume":"36","author":"Vandamme","year":"2013","journal-title":"Syst Appl Microbiol"},{"key":"2026012303405554600_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijantimicag.2009.08.015","article-title":"In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods","volume":"35","author":"Almuzara","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"2026012303405554600_bib9","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1128\/JCM.00728-12","article-title":"Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans","volume":"50","author":"Ridderberg","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2026012303405554600_bib10","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.20604","article-title":"Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989\u20132003)","volume":"101","author":"Aisenberg","year":"2004","journal-title":"Cancer"},{"key":"2026012303405554600_bib11","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1128\/JCM.02571-10","article-title":"Achromobacter xylosoxidans infection presenting as a pulmonary nodule mimicking cancer","volume":"49","author":"Claassen","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2026012303405554600_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/clinids\/14.2.479","article-title":"Bacteremia due to Achromobacter xylosoxidans in patients with cancer","volume":"14","author":"Legrand","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2026012303405554600_bib13","article-title":"Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe","author":"Adam","year":"2013","journal-title":"Br J Haematol"},{"key":"2026012303405554600_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2005.03.031","article-title":"A novel bacterium Achromobacter xylosoxidans as a cause of liver abscess: three case reports","volume":"43","author":"Asano","year":"2005","journal-title":"J Hepatol"},{"key":"2026012303405554600_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1086\/663710","article-title":"Investigation and control of an outbreak of Achromobacter xylosoxidans bacteremia","volume":"33","author":"Behrens-Muller","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026012303405554600_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01643962","article-title":"Infections due to Achromobacter xylosoxidans: case report and review of the literature","volume":"14","author":"Chandrasekar","year":"1986","journal-title":"Infection"},{"key":"2026012303405554600_bib17","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1155\/2011\/527412","article-title":"Achromobacter species endocarditis: a case report and literature review","volume":"22","author":"Derber","year":"2011","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2026012303405554600_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0195-6701(88)90115-6","article-title":"Outbreak of infection with Achromobacter xylosoxidans from contaminated intravascular pressure transducers","volume":"12","author":"Gahrn-Hansen","year":"1988","journal-title":"J Hosp Infect"},{"key":"2026012303405554600_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s10096-003-0925-3","article-title":"Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases","volume":"22","author":"G\u00f3mez-Cerezo","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026012303405554600_bib20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00284-012-0213-5","article-title":"Achromobacter xylosoxidans: an emerging pathogen carrying different elements involved in horizontal genetic transfer","volume":"65","author":"Traglia","year":"2012","journal-title":"Curr Microbiol"},{"key":"2026012303405554600_bib21","first-page":"58","article-title":"Infections with Achromobacter xylosoxidans","volume":"27","author":"Puthucheary","year":"1986","journal-title":"Singapore Med J"},{"key":"2026012303405554600_bib22","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/ICO.0b013e3181a1658f","article-title":"Clinical, microbiological profile and treatment outcome of ocular infections caused by Achromobacter xylosoxidans","volume":"28","author":"Reddy","year":"2009","journal-title":"Cornea"},{"key":"2026012303405554600_bib23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10096-005-0028-4","article-title":"Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit","volume":"24","author":"Tena","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026012303405554600_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/00365540701558714","article-title":"Urinary tract infection due to Achromobacter xylosoxidans: report of 9 cases","volume":"40","author":"Tena","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"2026012303405554600_bib25","article-title":"Skin and soft tissue infection caused by Achromobacter xylosoxidans: report of 14 cases","author":"Tena","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"2026012303405554600_bib26","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1128\/JCM.00494-13","article-title":"Molecular characterization of Achromobacter isolates from cystic fibrosis and non\u2013cystic fibrosis patients in Madrid, Spain","volume":"51","author":"Barrado","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2026012303405554600_bib27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcf.2012.10.002","article-title":"Identification and distribution of Achromobacter species in cystic fibrosis","volume":"12","author":"Spilker","year":"2013","journal-title":"J Cyst Fibros"},{"key":"2026012303405554600_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1699-0463.1988.tb05288.x","article-title":"Studies on ampicillin resistance in Achromobacter xylosoxidans: brief report","volume":"96","author":"Gahrn-Hansen","year":"1988","journal-title":"APMIS"},{"key":"2026012303405554600_bib29","doi-asserted-by":"crossref","first-page":"e68484","DOI":"10.1371\/journal.pone.0068484","article-title":"Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes","volume":"8","author":"Jakobsen","year":"2013","journal-title":"PLoS ONE"},{"key":"2026012303405554600_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1179\/joc.2009.21.3.253","article-title":"Antibiotic susceptibility profiles of uncommon bacterial species causing severe infections in Italy","volume":"21","author":"Nicolosi","year":"2009","journal-title":"J Chemother"},{"key":"2026012303405554600_bib31","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/j.1462-2920.2012.02789.x","article-title":"The impact of copper, nitrate and carbon status on the emission of nitrous oxide by two species of bacteria with biochemically distinct denitrification pathways","volume":"14","author":"Felgate","year":"2012","journal-title":"Environ Microbiol"},{"key":"2026012303405554600_bib32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.marpolbul.2013.05.002","article-title":"Isolation and characterization of alkane degrading bacteria from petroleum reservoir waste water in Iran (Kerman and Tehran provenances)","volume":"73","author":"Hassanshahian","year":"2013","journal-title":"Mar Pollut Bull"},{"key":"2026012303405554600_bib33","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.scitotenv.2013.06.068","article-title":"Arsenic-tolerant, arsenite-oxidising bacterial strains in the contaminated soils of West Bengal, India","volume":"463-464","author":"Majumder","year":"2013","journal-title":"Sci Total Environ"},{"key":"2026012303405554600_bib34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10096-007-0311-7","article-title":"Outbreak of Achromobacter xylosoxidans pseudobacteremia in a neonatal care unit related to contaminated chlorhexidine solution","volume":"26","author":"Molina-Cabrillana","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026012303405554600_bib35","first-page":"277","article-title":"Alcaligenes xylosoxidans\u2014a pathogen of chronic ear infection [in Polish]","volume":"59","author":"Wiatr","year":"2005","journal-title":"Otolaryngol Pol"},{"key":"2026012303405554600_bib36","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1128\/AAC.00548-06","article-title":"Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children","volume":"50","author":"Qin","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012303405554600_bib37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/AAC.00691-08","article-title":"In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis\u2013associated bacterial species","volume":"53","author":"LiPuma","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012303405554600_bib38","article-title":"Community acquired Achromobacter bronchopneumonia","author":"Swenson","year":"2014"},{"key":"2026012303405554600_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1574-695X.2000.tb01414.x","article-title":"Endotoxic activity of lipopolysaccharides isolated from emergent potential cystic fibrosis pathogens","volume":"27","author":"Hutchison","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2026012303405554600_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1096\/fasebj.8.2.8119492","article-title":"Bacterial endotoxin: molecular relationships of structure to activity and function","volume":"8","author":"Rietschel","year":"1994","journal-title":"FASEB J"},{"key":"2026012303405554600_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.micro.50.1.285","article-title":"The biochemistry and genetics of capsular polysaccharide production in bacteria","volume":"50","author":"Roberts","year":"1996","journal-title":"Annu Rev Microbiol"},{"key":"2026012303405554600_bib42","article-title":"Targeting the type III secretion system to treat bacterial infections","author":"Marshall","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"2026012303405554600_bib43","article-title":"The Bordetella bronchiseptica type III secretion system is required for persistence and disease severity but not transmission in swine","author":"Nicholson","year":"2013","journal-title":"Infect Immun"},{"key":"2026012303405554600_bib44","doi-asserted-by":"crossref","first-page":"e81792","DOI":"10.1371\/journal.pone.0081792","article-title":"In the absence of effector proteins, the Pseudomonas aeruginosa type three secretion system needle tip complex contributes to lung injury and systemic inflammatory responses","volume":"8","author":"Audia","year":"2013","journal-title":"PLoS ONE"},{"key":"2026012303405554600_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0005-2728(05)80274-9","article-title":"Spectral properties of Achromobacter xylosoxidans cytochromes c\u2032 and their NO complexes","volume":"1058","author":"Iwasaki","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"2026012303405554600_bib46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/S1517-83822009000200013","article-title":"Genetic diversity of siderophore-producing bacteria of tobacco rhizosphere","volume":"40","author":"Tian","year":"2009","journal-title":"Braz J Microbiol"},{"key":"2026012303405554600_bib47","first-page":"3","article-title":"Phosphatidylcholine-specific phospholipase C from Achromobacter xylosoxidans","volume":"29","author":"Ivanov","year":"1993","journal-title":"Acta Microbiol Bulg"},{"key":"2026012303405554600_bib48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0378-4347(91)80169-D","article-title":"Purification and some properties of phospholipase C from Achromobacter xylosoxidans","volume":"568","author":"Kostadinova","year":"1991","journal-title":"J Chromatogr A"},{"key":"2026012303405554600_bib49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-2478(94)00158-8","article-title":"Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens","volume":"43","author":"Green","year":"1994","journal-title":"Immunol Lett"},{"key":"2026012303405554600_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/B:MCBI.0000038215.89821.7f","article-title":"Down-regulation of inducible nitric oxide synthase by lysophosphatidic acid in human respiratory epithelial cells","volume":"262","author":"Kadowaki","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"2026012303405554600_bib51","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.4049\/jimmunol.170.12.6217","article-title":"Induction of macrophage nitric oxide production by gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5\/Toll-like receptor 4 complexes","volume":"170","author":"Mizel","year":"2003","journal-title":"J Immunol"},{"key":"2026012303405554600_bib52","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jcf.2011.07.004","article-title":"Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment","volume":"10","author":"Ridderberg","year":"2011","journal-title":"J Cyst Fibros"},{"key":"2026012303405554600_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MCP.0b013e32835f1afc","article-title":"Respiratory bacterial infections in cystic fibrosis","volume":"19","author":"Ciofu","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"2026012303405554600_bib54","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10096-011-1182-5","article-title":"Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients","volume":"30","author":"Lambiase","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026012303405554600_bib55","first-page":"284","article-title":"Achromobacter xylosoxidans bacteremia in patients with hematologic malignancies","volume":"83","author":"Hern\u00e1ndez","year":"1998","journal-title":"Haematologica"},{"key":"2026012303405554600_bib56","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/ajcp\/70.4.712","article-title":"Community-acquired bacteremic Achromobacter xylosoxidans type IIIa pneumonia in a patient with idiopathic IgM deficiency","volume":"70","author":"Dworzack","year":"1978","journal-title":"Am J Clin Pathol"},{"key":"2026012303405554600_bib57","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/AAC.01243-12","article-title":"Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump","volume":"57","author":"Bador","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012303405554600_bib58","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","article-title":"Aminoglycoside resistance in Pseudomonas aeruginosa","volume":"49","author":"Poole","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012303405554600_bib59","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/AAC.46.6.2014-2016.2002","article-title":"Detection of a variant metallo-beta-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an Alcaligenes xylosoxidans strain","volume":"46","author":"Iyobe","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012303405554600_bib60","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1128\/AAC.00341-11","article-title":"First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM","volume":"55","author":"Bador","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012303405554600_bib61","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s002030050339","article-title":"Tetracyclines: antibiotic action, uptake, and resistance mechanisms","volume":"165","author":"Schnappinger","year":"1996","journal-title":"Arch Microbiol"},{"key":"2026012303405554600_bib62","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4067\/S0716-10182012000600019","article-title":"Case report: respiratory infection due to Alcaligenes xylosoxidans in a patient with Mounier-Kuhn syndrome [in Spanish]","volume":"29","author":"Arroyo-C\u00f3zar","year":"2012","journal-title":"Rev Chilena Infectol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/12\/2\/252\/66487506\/annalsats_12_2_252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/12\/2\/252\/66487506\/annalsats_12_2_252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:41:16Z","timestamp":1769157676000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/12\/2\/252\/8429399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":62,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,1]]},"published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201406-288fr","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,2]]},"published":{"date-parts":[[2015,2,1]]}}}